Abstract
Nontuberculous mycobacteria (NTM), otherwise known as atypical mycobacteria, primarily cause pulmonary disease. However, with the increase in the immunocompromised population, infections caused by NTM at extrapulmonary (EP) sites have been on the rise in the past decade. Clinical presentations can commonly include lymphadenitis and skin and soft tissue infections. The diagnosis is challenging due to the invasive nature of the sample collection and the low degree of suspicion. Furthermore, detection up to the speciation level is important as management is species-specific. With limited data and studies regarding extrapulmonary nontuberculous mycobacteria (EP-NTM) disease, a multidisciplinary approach with awareness is required to recognize the pathogen early for appropriate and timely institution of therapy.